Biomarker validation in the emergency department. General criteria and clinical implications
The routine use of biomarkers, which is also rapidly expanding in the emergency department, carries some potential drawbacks such as the risk of producing false positive results and also places a substantial economical burden on the healthcare system, especially when the use of laboratory resources...
Main Authors: | Giuseppe Lippi, Camilla Mattiuzzi, Gianfranco Cervellin |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2014-03-01
|
Series: | Emergency Care Journal |
Subjects: | |
Online Access: | http://www.pagepressjournals.org/index.php/ecj/article/view/1860 |
Similar Items
-
Trends of popularity of cardiac biomarkers: Insights from Google Trends
by: Giuseppe Lippi, et al.
Published: (2018-12-01) -
Diagnosing myocardial injury in the high-sensitivity troponin era
by: Giuseppe Lippi, et al.
Published: (2018-12-01) -
Counterpoint: highly-sensitive troponin immunoassays in the emergency department
by: Giuseppe Lippi, et al.
Published: (2013-09-01) -
Seasonal variation in the frequency of myocardial infarction diagnosed in a large emergency department of a European country with a temperate climate
by: Giuseppe Lippi, et al.
Published: (2015-12-01) -
Cardiac enzyme in emergency medicine
by: Samad Shams Vahdati, et al.
Published: (2015-05-01)